Canada Life’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.34M | Sell |
25,154
-1,148
| -4% | -$102K | ﹤0.01% | 1098 |
|
|
2025
Q4 | $2.11M | Sell |
26,302
-6,683
| -20% | -$560K | ﹤0.01% | 1143 |
|
|
2025
Q3 | $3.19M | Sell |
32,985
-2,565
| -7% | -$207K | ﹤0.01% | 1021 |
|
|
2025
Q2 | $2.48M | Sell |
35,550
-1,484
| -4% | -$84.7K | ﹤0.01% | 1106 |
|
|
2025
Q1 | $1.84M | Sell |
37,034
-714
| -2% | -$45.1K | ﹤0.01% | 1224 |
|
|
2024
Q4 | $2.63M | Sell |
37,748
-1,272
| -3% | -$106K | ﹤0.01% | 1139 |
|
|
2024
Q3 | $4.09M | Buy |
39,020
+6,053
| +18% | +$708K | 0.01% | 975 |
|
|
2024
Q2 | $4.69M | Sell |
32,967
-5,509
| -14% | -$635K | 0.01% | 855 |
|
|
2024
Q1 | $4.29M | Sell |
38,476
-10,649
| -22% | -$1.27M | 0.01% | 881 |
|
|
2023
Q4 | $6.35M | Sell |
49,125
-917
| -2% | -$126K | 0.01% | 672 |
|
|
2023
Q3 | $8.16M | Buy |
50,042
+231
| +0.5% | +$40.6K | 0.02% | 569 |
|
|
2023
Q2 | $9.15M | Buy |
49,811
+7,991
| +19% | +$1.15M | 0.02% | 541 |
|
|
2023
Q1 | $5.57M | Sell |
41,820
-2,447
| -6% | -$287K | 0.01% | 695 |
|
|
2022
Q4 | $3.52M | Sell |
44,267
-2,366
| -5% | -$167K | 0.01% | 929 |
|
|
2022
Q3 | $2.82M | Buy |
46,633
+8,496
| +22% | +$549K | 0.01% | 973 |
|
|
2022
Q2 | $2.09M | Buy |
38,137
+9,212
| +32% | +$534K | 0.01% | 1138 |
|
|
2022
Q1 | $2.24M | Buy |
28,925
+209
| +0.7% | +$14.3K | ﹤0.01% | 1145 |
|
|
2021
Q4 | $2.14M | Sell |
28,716
-34
| -0.1% | -$2.01K | ﹤0.01% | 1173 |
|
|
2021
Q3 | $1.36M | Hold |
28,750
| – | – | ﹤0.01% | 1387 |
|
|
2021
Q2 | $1.16M | Sell |
28,750
-548
| -2% | -$22.7K | ﹤0.01% | 1452 |
|
|
2021
Q1 | $1.2M | Sell |
29,298
-3,425
| -10% | -$128K | ﹤0.01% | 1428 |
|
|
2020
Q4 | $953K | Sell |
32,723
-3,843
| -11% | -$99.4K | ﹤0.01% | 1526 |
|
|
2020
Q3 | $805K | Sell |
36,566
-3,090
| -8% | -$78.8K | ﹤0.01% | 1497 |
|
|
2020
Q2 | $1.1M | Sell |
39,656
-2,978
| -7% | -$72.6K | ﹤0.01% | 1394 |
|
|
2020
Q1 | $778K | Buy |
42,634
+2,981
| +8% | +$69.3K | ﹤0.01% | 1417 |
|
|
2019
Q4 | $948K | Buy |
+39,653
| New | +$835K | ﹤0.01% | 1519 |
|
|
2019
Q3 | – | Sell |
-45,039
| Closed | -$677K | – | 1123 |
|
|
2019
Q2 | $677K | Buy |
+45,039
| New | +$805K | ﹤0.01% | 1683 |
|
|
2019
Q1 | – | Sell |
-42,155
| Closed | -$692K | – | 2557 |
|
|
2018
Q4 | $692K | Hold |
42,155
| – | – | ﹤0.01% | 1558 |
|
|
2018
Q3 | $826K | Hold |
42,155
| – | – | ﹤0.01% | 1599 |
|
|
2018
Q2 | $832K | Hold |
42,155
| – | – | ﹤0.01% | 1597 |
|
|
2018
Q1 | $1.03M | Buy |
42,155
+1,055
| +3% | +$27.7K | ﹤0.01% | 1501 |
|
|
2017
Q4 | $1.18M | Buy |
41,100
+38,000
| +1,226% | +$1.2M | ﹤0.01% | 1465 |
|
|
2017
Q3 | $81K | Hold |
3,100
| – | – | ﹤0.01% | 2205 |
|
|
2017
Q2 | $65K | Buy |
+3,100
| New | +$65.5K | ﹤0.01% | 2244 |
|
|
2014
Q2 | – | Sell |
-317
| Closed | -$3K | – | 2420 |
|
|
2014
Q1 | $3K | Buy |
+317
| New | +$2.92K | ﹤0.01% | 2258 |
|
Other funds holding ACLS
VPM
RP
VCM
Canada Life's ACLS Position: Q1 2026 in Review
Canada Life reduced its Axcelis (ACLS) stake by 4.4% in Q1 2026, selling an estimated $102K and leaving 25,154 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1098.
Canada Life first reported a position in ACLS in Q1 2014 and has held it in 35 quarters since. The position peaked at $9.15M in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Canada Life held 25,154 shares of Axcelis worth $2.34M as of Q1 2026.
- Canada Life sold 1,148 Axcelis shares in Q1 2026, an estimated $102K.
- Axcelis made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1098 holding.
- Canada Life first reported a position in Axcelis in Q1 2014 and has held it in 35 quarters since.
- Canada Life's Axcelis position peaked at $9.15M in Q2 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.